Cwm, LLC Scynexis Inc Transaction History
Cwm, LLC
- $33.3 Billion
- Q3 2025
A detailed history of Cwm, LLC transactions in Scynexis Inc stock. As of the latest transaction made, Cwm, LLC holds 191 shares of SCYX stock, worth $120. This represents 0.0% of its overall portfolio holdings.
Number of Shares
191
Previous 191
-0.0%
Holding current value
$120
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding SCYX
# of Institutions
48Shares Held
10.6MCall Options Held
0Put Options Held
0-
Kingdon Capital Management, L.L.C. New York, NY2.24MShares$1.41 Million0.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.66MShares$1.04 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.58MShares$997,5090.0% of portfolio
-
Avidity Partners Management LP Dallas, TX1.23MShares$774,2130.22% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC556KShares$349,9990.7% of portfolio
About SCYNEXIS INC
- Ticker SCYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 32,651,800
- Market Cap $20.6M
- Description
- SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...